Survivors of pediatric retinoblastoma have few cognitive and social problems during adulthood
the ONA take:
According to a new study published online in the journal Cancer, researchers have found that adults who survived childhood retinoblastoma have limited cognitive and social issues later in life.
For the study, researchers at St. Jude Children's Research Hospital in Memphis, Tennessee, sought to investigate the long-term health issues of survivors of the eye cancer following diagnosis and treatment. Although most children are cured of the disease, survivors have a higher risk of long-term health effects from intensive treatments.
The researchers identified 69 adult survivors of childhood retinoblastoma who were 33 years old on average and were treated for the treated an average of 31 years earlier. Participants then completed cognitive evaluations and questionnaires.
Results showed that survivors had few cognitive and social problems. In addition, researchers found that patients who received whole brain radiation treatment had a poorer performance on short-term and long-term verbal memory tasks.
They also found that survivors who were diagnosed before age 1 had a significantly better performance on short-term and long-term verbal memory tasks, verbal learning tasks, and verbal reasoning measures compared with those diagnosed after age 1. The researchers suggest that the brain is able to adapt and reorganize following early treatment.
Adults who survived childhood retinoblastoma have limited cognitive and social issues later in life.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|